Post by sunny3999 on May 1, 2014 0:32:35 GMT -5
Dear Mannkind Message Board Member,
we are in a battle in "wording" the headline from a report of MD PhD. (Prof.) Schatz which is the leader of Endocrinology in Europe/Germany.
He wrote: at the beginning FDA denied approval and changed wording after our intervention to....
Inhaled insulin preparation AFREZZA "not re-authorized" by American FDA Drug Administration
which is a misleading of Doctors and Patients in point of Afrezza's outcome after the Adcom vote and discussion.
We wrote him several times to change the wording answered and he agreed at the last standpoint in his answer:
Only: The FDA has approved a few days later AFREZZA "still not (yet) approved" and "postponed" the decision until later.
Have patience, and yet we wait the next meeting to AFREZZA from.
Helmut Schatz
without changing the headline!
The battle is not only the FDA its the Society and Lobby of the Pharmaindustry which will do everything to give a bad image af "Afrezza" and Mannkind.
translate.google.de/translate?hl=en&sl=de&u=http://blog.endokrinologie.net/insulinpraeparat-fda-nicht-zugelassen-1224/&prev=/search%3Fq%3DInhalierbares%2BInsulinpr%25C3%25A4parat%2BAfrezza%2Berneut%2Bvon%2BAmerikanischer%2BArzneibeh%25C3%25B6rde%2BFDA%2Bnicht%2Bzugelassen%26biw%3D1366%26bih%3D705
I will keep you informed.
Sunny3999
we are in a battle in "wording" the headline from a report of MD PhD. (Prof.) Schatz which is the leader of Endocrinology in Europe/Germany.
He wrote: at the beginning FDA denied approval and changed wording after our intervention to....
Inhaled insulin preparation AFREZZA "not re-authorized" by American FDA Drug Administration
which is a misleading of Doctors and Patients in point of Afrezza's outcome after the Adcom vote and discussion.
We wrote him several times to change the wording answered and he agreed at the last standpoint in his answer:
Only: The FDA has approved a few days later AFREZZA "still not (yet) approved" and "postponed" the decision until later.
Have patience, and yet we wait the next meeting to AFREZZA from.
Helmut Schatz
without changing the headline!
The battle is not only the FDA its the Society and Lobby of the Pharmaindustry which will do everything to give a bad image af "Afrezza" and Mannkind.
translate.google.de/translate?hl=en&sl=de&u=http://blog.endokrinologie.net/insulinpraeparat-fda-nicht-zugelassen-1224/&prev=/search%3Fq%3DInhalierbares%2BInsulinpr%25C3%25A4parat%2BAfrezza%2Berneut%2Bvon%2BAmerikanischer%2BArzneibeh%25C3%25B6rde%2BFDA%2Bnicht%2Bzugelassen%26biw%3D1366%26bih%3D705
I will keep you informed.
Sunny3999
